Želmina Babić

Želmina Babić is a medical doctor specializing in pharmacovigilance and drug safety, with extensive experience in medical review of individual case safety reports (ICSRs) across various clinical trial phases. They have worked as a Drug Safety Physician at SGS and as a PV Physician at PrimeVigilance Ltd., where they conducted medical reviews of adverse events and literature. Currently, Želmina holds a position as a Global Development Medical Scientist Director in Late Development Oncology at AstraZeneca. They are pursuing a Master's degree in Medicine at the University of Belgrade.